Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |